FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Pharmacology Pediatric Studies Guidance

FDA publishes a draft guidance on general clinical pharmacology considerations for pediatric studies of drugs, including biologics.

latest-news-card-1
Medical Devices

Philips Respironics Recalls 17 Million Airway Masks

Philips Respironics recalls 17 million masks used with bilevel positive airway pressure machines and continuous positive airway pressure machines due ...

latest-news-card-1
Federal Register

Panel to Discuss EUA for Covid-19 Therapy

Federal Register notice: FDA announces a 10/6 advisory committee meeting to discuss a Veru Inc. request for an emergency use authorization for tubulin...

latest-news-card-1
Federal Register

Priority Voucher Used on Genentechs Vabysmo Approval

Federal Register notice: FDA announces that a product was approved using a priority review voucher Genentechs Vabysmo (faricimab-svoa).

latest-news-card-1
Human Drugs

CDER, CBER Accept 1st ISTAND Submission

CDER and CBER accept the first letter of intent submission for the new Innovative Science and Technology Approaches for New Drugs pilot program to dev...

latest-news-card-1
Human Drugs

Ionis/AstraZeneca Planning NDA for Eplontersen

After reporting new clinical trial data, Ionis Pharmaceuticals and AstraZeneca plan to submit an NDA for eplontersen for treating patients with heredi...

Human Drugs

Stakeholders Want Changes to Supply Chain Guidance

Four drug industry stakeholders ask FDA to clarify elements in a draft guidance on interoperable exchange of information under the Drug Supply Chain S...

latest-news-card-1
Human Drugs

Pacira Seeking Expanded Label on Exparel

Pacira BioSciences plans to submit a supplemental NDA early next year to broaden the label on its post-surgical pain drug Exparel (bupivacaine extende...

latest-news-card-1
Biologics

CBER Webinar 10/5 on Study Data Standards

CBER announces a 10/5 Webinar entitled Study Data Standards Update for CBER: Your Guide to a Successful Submission.

FDA General

2nd Time a Charm in ALS Drug Panel Vote

In an unusual second advisory committee meeting in six months, panel members reverse their March vote and recommend approval for Amylyxs amyotrophic l...